Last reviewed · How we verify
NCT05192447: REHABrain
The Cognitive-Behavioral Dysfunctions and the Potential of Neuroplasticity in Brain Tumors Patients During Radiotherapy
NA trial testing Exercise treatment in Brain Tumors in 150 participants. Status unknown.
31 March 2025
Quick facts
| Lead sponsor | The Greater Poland Cancer Centre |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 150 |
| Start date | 1 April 2021 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Exercise treatment
Conditions studied
- Brain Tumors — all drugs for Brain Tumors →
- Radiotherapy — all drugs for Radiotherapy →
Sponsor
The Greater Poland Cancer Centre — full company profile →
Who can join
Adults 18 to 70, any sex, with Brain Tumors or Radiotherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Primary and secondary brain tumors are a constant challenge for the medicine. Tissue sensitivity to ionizing radiation differs and depends on numerous factors and the same dose of radiation may produce different effects in particular structures of the CNS. It can also affect the surrounding healthy tissues and lead to adverse effects like the cognitive or physical function impairment. One of brain structures most sensitive to ionizing radiation is the limbic system, especially the hippocampus, because it is here that the postnatal neurogenesis takes place via neural stem cells, which are a self-renewing population of precursor cells. There have been no studies that would thoroughly examine the impact of different CNS radiation therapy techniques on the cognitive function, potential neuroplasticity markers or blood-brain barrier damage in brain tumor patients with a concomitant use of neurocognitive combination therapies or physical exercise, and their impact on the CNS function. The aim of the study is to assess the impact of selected RT techniques: IMRT, WBRT, and CyberKnife (SRS) on the processes regulating cognitive and physical function in patients with primary (Group III and IV, WHO, 2016) and metastatic CNS tumors. The secondary objective is the analysis of the effect of selected forms of neurorehabilitation on the parameters studied. The study will be a prospective clinical trial conducted in 150 patients. Patient evaluation will be carried out before RT, after RT, during a follow-up visit-3 months after RT, and finally after 6 months. The methods will be used: analysis of the blood-brain barrier permeability markers including exact connection proteins, markers confirming neuroplasticity of the brain, cerebral secretory activity, and onco- and anti-neuronal antibody activity, brain structure analysis (MRI) and volume testing of selected brain structures, and assessment of cognitive and physical function of the patients. The study will be a part of the search trend aiming to explain the mechanism of the formation of cognitive-behavioral disorders in humans based on the most fundamental principles governing information processing in CNS, and the impact of neoplasia and ionizing radiation on selected brain structures and functions. The results of the study might become a starting point for the formulation of new guidelines on the level of physical activity or cognitive exercise in patients treated with CNS radiation therapy.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Rehabilitation Exercises Supported by Monitor-Augmented Reality for Patients with High-Grade Glioma Undergoing Radiotherapy: Results of a Randomized Clinical Trial.
Pieczyńska A, Zasadzka E, Pilarska A, Procyk D, et al · · 2023 · cited 10× · PMID 37959303 · DOI 10.3390/jcm12216838 -
Neural and Onconeural Autoantibodies and Blood-Brain Barrier Disruption Markers in Patients Undergoing Radiotherapy for High-Grade Primary Brain Tumour.
Hojan K, Adamska K, Lewandowska A, Procyk D, et al · · 2024 · cited 1× · PMID 38337823 · DOI 10.3390/diagnostics14030307 -
Does Personality Influence the Quality of Life of Patients with Brain Tumors Treated with Radiotherapy?
Pilarska A, Pieczyńska A, Adamska K, Hojan K. · · 2025 · PMID 39796758 · DOI 10.3390/cancers17010131 -
Psychological Characteristics Associated with Post-Treatment Physical Status and Quality of Life in Patients with Brain Tumor Undergoing Radiotherapy.
Pieczyńska A, Pilarska A, Adamska K, Zasadzka E, et al · · 2022 · PMID 36579602 · DOI 10.3390/jpm12111880
Verify or expand the search:
- PubMed search for NCT05192447
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exercise treatment
Trials testing the same drug.
- NCT04165811 — Effects of Aerobic Dance Based Exercise Program After Surgery in Obeses Awating Bariatric Surgery · NA · completed
- NCT03523325 — Achilles Tendinopathy, Treatment With eXercise Comparing Men and Women · NA · completed
- NCT04242381 — Short Term Effect of Kinesiotaping In Patients With Shoulder Impingement Syndrome · NA · completed
Other recruiting trials for Brain Tumors
Currently open trials in the same condition.
- NCT07126821 — A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data · recruiting
- NCT06442748 — Short Versus Long-term Levetiracetam in Brain Tumors · Phase 3 · recruiting
- NCT01117168 — Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group · active not recruiting
Other The Greater Poland Cancer Centre trials
Trials by the same sponsor.
- NCT07011316 — Subclinical Monitoring of Lymphatic Function in Oncology Patients for Lymphoedema Prevention (ONCOLYMPH) · recruiting
- NCT05715502 — Focal Salvage Brachytherapy Study (FocaSaBra) · NA · recruiting
- NCT05142202 — High Five (HiFi) Accelerated Partial Breast Irradiation Study · NA · unknown
- NCT04683549 — HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy · NA · unknown
- NCT06190600 — Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05192447 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Greater Poland Cancer Centre
- Last refreshed: 3 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05192447.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing